ART Bioscience LTD
General Data
Reg Number
515290930
Sector
Biomed
Established
2015
No. of Employees
7
Stage
R&D
Additional Funding
1
Description
The company is developing a gene-edited treatment for Duchenne based on an innovative delivery system (LNP) that reaches muscles and RNA tailored for muscle expression.
Technology
Art Bioscience leverages gene therapy, RNA technologies and gene editing platform to rugs for rare diseases.
Targeted Customers
People with Duchenne Muscular Dystrophy, Physicians.
Management personnel
Winning details
Route name
Winning year
R&D Program second/third year request for Entitled Growth Corporate
R&D Program second/third year request for Entitled Growth Corporate
2023
R&D Fund
R&D Fund
2025